About 40 generic companies enters ‘Twynsta’ market
Generics of ‘Twynsta(telmisartan, amlodipine),’ a leading drug in the hypertension complex market, are getting ready to be released.
As Twynsta lost the exclusivity with the expiration of the PMS(post-marketing surveillance) on the 18th of August, pharmaceutical companies getting ready to launch...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
